Relay Therapeutics, Inc. Common Stock (NASDAQ: RLAY) last traded at $19.44, down 1.32% on the session. The quote above updates while this page is open; the figures below are drawn from Relay Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Relay Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker RLAY. Its market capitalisation is $4.26 billion.
Valuation measures for Relay Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $4.26B |
|---|---|
| Enterprise value | $4.22B |
| Price / sales | 411.64 |
| Price / book | 4.79 |
| Beta | 1.58 |
Trailing-twelve-month figures tagged in Relay Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $10.35M |
|---|---|
| Net income (TTM) | -$286.04M |
| EPS (TTM) | -$1.56 |
| Operating margin | -2999.67% |
| Return on equity | -32.14% |
| Cash | $121.19M |
Range and volume for RLAY over the past 52 weeks.
| 52-week high | $21.27 |
|---|---|
| 52-week low | $3.43 |
| Volume | 2.20M |
| Average volume | 3.39M |
| Previous close | $19.70 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.